Journal of Traditional Chinese Medicine 2017

3 papers
The 2017 edition of the Journal of Traditional Chinese Medicine featured research focused on the molecular mechanisms and clinical applications of herbal formulations. Studies explored the biochemical pathways through which traditional treatments interact with modern physiological markers. For instance, research investigated Ruyanneixiao cream’s ability to block precancerous mammary lesions by interfering with glycolysis and hypoxia-inducible factor-1α. Another study utilized rat models to examine how Shenfuqiangxin Capsules inhibit apoptosis via the mitogen-activated protein kinase (MAPK) signaling pathway in cases of cardio-renal syndrome. Beyond experimental laboratory work, the journal published evidence-based assessments, including a systematic review and meta-analysis on rhubarb-based formulae for hepatic encephalopathy. Prolific contributors to the journal this year included authors such as Fengjie Bie, Xiaobo Li, and Yi Ma. The collective work from this period highlights an emphasis on integrating traditional herbal medicine with contemporary pharmacological analysis and systematic clinical evaluation to address complex pathological conditions.

Papers

Title
External use of Ruyanneixiao cream efficiently blocks precancerous mammary lesions by interfering with glycolysis induced by inhibition of hypoxia inducible factor-1α, hexokinase 2, phosphofructokinas
Rhubarb-based Chinese herbal formulae for hepatic encephalopathy: a systematic review and Meta-analysis
Shenfuqiangxin Capsule inhibits apoptosis through mitogen-activated protein kinase signal pathway in rats with cardio-renal syndrome induced by infrarenal aortic-clamping